Understanding and Treating Vascular Cognitive Impairment

@article{Gorelick2013UnderstandingAT,
  title={Understanding and Treating Vascular Cognitive Impairment},
  author={Philip B. Gorelick and David Nyenhuis},
  journal={CONTINUUM: Lifelong Learning in Neurology},
  year={2013},
  volume={19},
  pages={425–437}
}
  • P. Gorelick, D. Nyenhuis
  • Published 1 April 2013
  • Medicine, Biology, Psychology
  • CONTINUUM: Lifelong Learning in Neurology
Purpose of Review: It is estimated that one in three people will experience a stroke, dementia, or both during their lifetime. The goal of this article is to assist clinicians in the identification and treatment of patients with vascular cognitive impairment (VCI). To that end, we will discuss the scope and definition of VCI; how this definition can be applied in clinical practice; VCI epidemiology and pathogenesis, its clinical features, and assessment; and prevention and treatment of this… 
View on Wolters Kluwer
lsneuro.org
19 Citations
Highly Influential Citations
1
Background Citations
8

19 Citations

Citation Type

Citation Type

Pathogenesis and treatment of vascular cognitive impairment.
  • K. Jellinger
  • Medicine, Psychology
    Neurodegenerative disease management
  • 2014
Vascular cognitive impairment (VCI) defines a continuum of disorders ranging from mild cognitive impairment to full-blown dementia, attributable to cerebrovascular causes. Major morphological types -…
Latin American Delphi Consensus on Vascular Cognitive Impairment: Definitions, Clinical Features, Pathophysiology, Prevention and Treatment
TLDR
A global consensus was reached on the classification, pathophysiology, diagnosis and treatment of vascular cognitive impairment in Latin America and the results of this consensus allow the incorporation of the opinion and experience of physicians of different specialties inLatin America regarding the vascular Cognitive impairment.
Pharmacotherapy for Vascular Cognitive Impairment
TLDR
There is a need for more robust clinical trials focusing on executive function and other cognitive measures and incorporation of newer imaging modalities to provide additional evidence about the utility of these strategies in patients with VCI.
Vascular Cognitive Impairment and Post-Stroke Cognitive Deficits
  • Hyungsub Shim
  • Psychology, Biology
    Current Neurology and Neuroscience Reports
  • 2013
TLDR
With the more widespread acceptance of the AHA-ASA diagnostic criteria for VCI and its subtypes, perhaps the authors will start to see more in the way of compelling treatment trials.
Vascular cognitive impairment and dementia.
The Brain AT2R—a Potential Target for Therapy in Alzheimer’s Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics
TLDR
A comprehensive update on the major causes of dementia including the risk factors, current diagnostic criteria, pathophysiology, and contemporary treatment strategies is provided and the angiotensin II receptor type 2 (AT2R) is highlighted as an effective drug target.
Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia.
TLDR
The relevance and advantages of rodent models in elucidating the pathogenesis of VCID are discussed, the interplay between hypoperfusion and the deposition of amyloid β (Aβ) protein, as it relates to AD is explored and the use of such models is proposed for tackling the urgently needed translational gap from preclinical models to clinical treatments.
Genetic Markers in Biological Fluids for Aging-Related Major Neurocognitive Disorder
TLDR
The current diagnostic criteria consider cognitive decline leading to major NCD or dementia as a progressive degenerative process with an underlying neuropathology that begins before the manifestation of symptoms that may, in turn, accelerate the neurodegenerative process and its resultant behavioral and functional disorders.
CLINICAL AND RADIOLOGIC APPROACH TO PROBABLE MIXED DEMENTIA (VASCULAR DEMENTIA AND PROGRESSIVE SUPRANUCLEAR PALSY)
TLDR
An 80-year old male with dementia symptoms that was followed and regularly examined for one year and the working diagnosis was established, which consisted of probable vascular cognitive impairment and probable progressive supranuclear palsy.
Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
TLDR
It is concluded that metformin can improve cognitive function in patients with NDVCI and abnormal glucose metabolism, especially in terms of performance function.
...
1
2
...

References

SHOWING 1-10 OF 68 REFERENCES
Advances in vascular cognitive impairment.
TLDR
Vascular cognitive impairment (VCI) has continued to evolve over the past year with further work on risk factors, silent strokes, leukoaraiosis and lesion volume and location, and vascular risk factors confirmatory and new trial data have been scanty.
Vascular dementia
TLDR
These criteria for the diagnosis of vascular dementia are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible).
Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
TLDR
This scientific statement provides an overview of the evidence on vascular contributions to cognitive impairment and dementia and provides evidence that subcortical forms of VCI with white matter hyperintensities and small deep infarcts are common and risk markers for VCI are the same as traditional risk factors for stroke.
Advances in vascular cognitive impairment 2010.
TLDR
The contribution of small vessel disease (SVD) and its neuroimaging correlates and the role of CV risk factors are concentrated on.
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
TLDR
Using the same standards will help identify individuals in the early stages of cognitive impairment, will make studies comparable, and by integrating knowledge, will accelerate the pace of progress.
Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
  • M. Farlow
  • Medicine, Biology
    Mayo Clinic proceedings
  • 2006
TLDR
Clinical trials of donepezil, galantamine, and rivastigmine have supported the idea that cholinesterase inhibitors, which are indicated for the treatment of mild to moderate AD, may also provide benefit for patients with VaD, and antidementia drugs currently used for treatment of AD should be considered for Treatment of VaD.
Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease
TLDR
This study supports the vascular depression hypothesis by finding that patients with the severest WMLs showed not only a greater executive dysfunction, but also a minor response to antidepressant treatment.
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
TLDR
Mild cognitive impairment may be the earliest clinical manifestation of common age-related neurologic diseases in persons with dementia or those without cognitive impairment.
Incidence of Dementia, Alzheimer Disease, and Vascular Dementia in a Japanese Population: Radiation Effects Research Foundation Adult Health Study
TLDR
AD was the predominant type of dementia in this recent incidence study conducted in Japan, suggesting a reduction in vascular dementia (VaD) and an increase in AD.
Stroke and the risk of Alzheimer disease.
TLDR
Stoke is associated with AD among elderly individuals and the relation is strongest in the presence of known vascular risk factors, including hypertension, diabetes, and heart disease.
...
1
2
3
4
5
...